Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Debt: 2017-2024

Historic Non-Current Debt for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2024 value amounting to $56.2 million.

  • Organogenesis Holdings' Non-Current Debt fell 9.60% to $56.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $56.2 million, marking a year-over-year decrease of 9.60%. This contributed to the annual value of $60.7 million for FY2023, which is 8.28% down from last year.
  • Organogenesis Holdings' Non-Current Debt amounted to $56.2 million in Q3 2024, which was down 2.73% from $57.7 million recorded in Q2 2024.
  • In the past 5 years, Organogenesis Holdings' Non-Current Debt registered a high of $74.5 million during Q3 2021, and its lowest value of $37.3 million during Q2 2021.
  • Its 3-year average for Non-Current Debt is $63.7 million, with a median of $63.5 million in 2023.
  • Its Non-Current Debt has fluctuated over the past 5 years, first decreased by 29.58% in 2021, then soared by 84.95% in 2022.
  • Over the past 5 years, Organogenesis Holdings' Non-Current Debt (Quarterly) stood at $60.0 million in 2020, then rose by 17.95% to $70.8 million in 2021, then declined by 6.41% to $66.2 million in 2022, then declined by 8.28% to $60.7 million in 2023, then fell by 9.60% to $56.2 million in 2024.
  • Its Non-Current Debt stands at $56.2 million for Q3 2024, versus $57.7 million for Q2 2024 and $59.4 million for Q1 2024.